Table 1 : Groupes pronostiques Métastases cérébrales du Cancer du sein
D’apres Sperduto, IJROBP, 2012
Facteur
0
0.5
1.0
1.5
2.0
Index
de
Karnofsky
≤ 50
60
70-80
90-100
Type
moléculaire
Basal
-
Luminal A
HER2
Luminal B
Age
≥ 60 ans
< 60 ans
Etablissement
de
4
groupes
pronostiques
selon le score
1
1 à 2
2.5 à 3
> 3
Survie médiane en mois
3.4
7.7
15.2
25
1.
Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, et al.
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases
in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol Off J Eur Soc
Med Oncol ESMO. juin 2006;17(6):935
‑
44.
2.
Lin NU, Winer EP. Brain metastases: the HER2 paradigm. Clin Cancer Res Off J Am
Assoc Cancer Res. 15 mars 2007;13(6):1648
‑
55.
3.
Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. Effect of tumor
subtype on survival and the graded prognostic assessment for patients with breast
cancer and brain metastases. Int J Radiat Oncol Biol Phys. 1 avr 2012;82(5):2111
‑
7.
4.
Patil CG, Pricola K, Garg SK, Bryant A, Black KL. Whole brain radiation therapy
(WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Cochrane Database Syst Rev. 2010;(6):CD006121.
5.
Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al.
Neurocognition in patients with brain metastases treated with radiosurgery or
radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol.
nov 2009;10(11):1037
‑
44.
6.
Soon YY, Tham IWK, Lim KH, Koh WY, Lu JJ. Surgery or radiosurgery plus whole
brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane
Database Syst Rev. 2014;3:CD009454.
7.
Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, et al. Adjuvant
whole-brain radiotherapy versus observation after radiosurgery or surgical resection of
one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol
Off J Am Soc Clin Oncol. 10 janv 2011;29(2):134
‑
41.
8.
Yang TJ, Oh JH, Folkert MR, Gupta G, Shi W, Zhang Z, et al. Outcomes and
prognostic factors in women with 1 to 3 breast cancer brain metastases treated with
definitive stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 1 nov
